0.92 CAD
(1.91%)
Create an alert
Stocks and Shares ISADirector deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 1,779 | 49.80 CAD | 88,594.20 CAD | 17,716 |
| 30 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 136 | 50.01 CAD | 6,801.36 CAD | 17,716 |
| 30 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 64 | 50.05 CAD | 3,203.20 CAD | 17,716 |
| 30 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 225 | 49.90 CAD | 11,227.50 CAD | 17,716 |
| 19 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Option/Award related | 7,560 | 51.60 CAD | 390,126.00 CAD | 0 |
| 19 June 2026 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 1,810 | 51.39 CAD | 93,012.00 CAD | 0 |
| 19 June 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Option/Award related | 3,748 | 51.57 CAD | 193,284.36 CAD | 17,716 |
| 19 June 2026 | Sandra SandersonChief Marketing Officer | Sell Option/Award related | 886 | 51.40 CAD | 45,540.40 CAD | 1,504 |
| 13 April 2026 | Jo Mark ZurelDirector | Buy Regular purchase transaction | 2,000 | 48.48 CAD | 96,960.00 CAD | 7,000 |
| 17 March 2026 | Douglas Bigler NathansonGeneral Counsel | Sell Regular sell transaction (market) | 2,000 | 51.10 CAD | 102,206.00 CAD | 16,389 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 July 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 54,985 | 56.98 CAD | 3,133,000.00 CAD | 0 |
| 14 July 2025 | Michael Bennett MedlinePresident/CEO | Sell Option/Award related | 45,015 | 56.51 CAD | 2,543,797.65 CAD | 142,701 |
| 11 July 2025 | CLASS B HOLDINGS LTDFamily Holding | Buy Regular purchase transaction | 31,594 | 54.40 CAD | 1,718,713.60 CAD | 32,620,457 |
| 11 July 2025 | CLASS B HOLDINGS LTDFamily Holding | Buy Regular purchase transaction | 29,754 | 54.40 CAD | 1,618,617.60 CAD | 30,720,071 |
| 11 July 2025 | CLASS B HOLDINGS LTDFamily Holding | Buy Regular purchase transaction | 28,652 | 54.40 CAD | 1,558,668.80 CAD | 29,582,564 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.